Cargando…

Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

The assessment of fibrosis in chronic liver diseases using non-invasive methods is an important topic in hepatology. The aim of this study is to identify patients with non-alcoholic fatty liver disease (NAFLD) and advanced liver fibrosis by establishing correlations between biological/ultrasound mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Olteanu, Vasile-Andrei, Balan, Gheorghe G., Timofte, Oana, Dascalu, Cristina Gena, Gologan, Elena, Gilca-Blanariu, Georgiana-Emanuela, Diac, Madalina-Maria, Sandu, Ion, Stefanescu, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498120/
https://www.ncbi.nlm.nih.gov/pubmed/36140537
http://dx.doi.org/10.3390/diagnostics12092136
_version_ 1784794678130900992
author Olteanu, Vasile-Andrei
Balan, Gheorghe G.
Timofte, Oana
Dascalu, Cristina Gena
Gologan, Elena
Gilca-Blanariu, Georgiana-Emanuela
Diac, Madalina-Maria
Sandu, Ion
Stefanescu, Gabriela
author_facet Olteanu, Vasile-Andrei
Balan, Gheorghe G.
Timofte, Oana
Dascalu, Cristina Gena
Gologan, Elena
Gilca-Blanariu, Georgiana-Emanuela
Diac, Madalina-Maria
Sandu, Ion
Stefanescu, Gabriela
author_sort Olteanu, Vasile-Andrei
collection PubMed
description The assessment of fibrosis in chronic liver diseases using non-invasive methods is an important topic in hepatology. The aim of this study is to identify patients with non-alcoholic fatty liver disease (NAFLD) and advanced liver fibrosis by establishing correlations between biological/ultrasound markers and non-invasively measured liver stiffness. This study enrolled 116 patients with non-alcoholic fatty liver disease, which were evaluated clinically, biologically, and by ultrasound. Liver fibrosis was quantified by measuring liver stiffness by shear wave elastography (SWE). Multiple correlation analysis of predictors of liver fibrosis identified a number of clinical, biological, and ultrasound parameters (BMI, blood glucose, albumin, platelet count, portal vein diameter, bipolar spleen diameter) that are associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. The correlations between the degree of liver fibrosis and the risk values of some serological and ultrasound markers obtained in our study could be useful in clinical practice for the identification of advanced fibrosis in patients with NAFLD.
format Online
Article
Text
id pubmed-9498120
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94981202022-09-23 Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease Olteanu, Vasile-Andrei Balan, Gheorghe G. Timofte, Oana Dascalu, Cristina Gena Gologan, Elena Gilca-Blanariu, Georgiana-Emanuela Diac, Madalina-Maria Sandu, Ion Stefanescu, Gabriela Diagnostics (Basel) Article The assessment of fibrosis in chronic liver diseases using non-invasive methods is an important topic in hepatology. The aim of this study is to identify patients with non-alcoholic fatty liver disease (NAFLD) and advanced liver fibrosis by establishing correlations between biological/ultrasound markers and non-invasively measured liver stiffness. This study enrolled 116 patients with non-alcoholic fatty liver disease, which were evaluated clinically, biologically, and by ultrasound. Liver fibrosis was quantified by measuring liver stiffness by shear wave elastography (SWE). Multiple correlation analysis of predictors of liver fibrosis identified a number of clinical, biological, and ultrasound parameters (BMI, blood glucose, albumin, platelet count, portal vein diameter, bipolar spleen diameter) that are associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. The correlations between the degree of liver fibrosis and the risk values of some serological and ultrasound markers obtained in our study could be useful in clinical practice for the identification of advanced fibrosis in patients with NAFLD. MDPI 2022-09-02 /pmc/articles/PMC9498120/ /pubmed/36140537 http://dx.doi.org/10.3390/diagnostics12092136 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Olteanu, Vasile-Andrei
Balan, Gheorghe G.
Timofte, Oana
Dascalu, Cristina Gena
Gologan, Elena
Gilca-Blanariu, Georgiana-Emanuela
Diac, Madalina-Maria
Sandu, Ion
Stefanescu, Gabriela
Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
title Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
title_full Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
title_fullStr Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
title_full_unstemmed Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
title_short Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
title_sort risk predictors of advanced fibrosis in non-alcoholic fatty liver disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498120/
https://www.ncbi.nlm.nih.gov/pubmed/36140537
http://dx.doi.org/10.3390/diagnostics12092136
work_keys_str_mv AT olteanuvasileandrei riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT balangheorgheg riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT timofteoana riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT dascalucristinagena riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT gologanelena riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT gilcablanariugeorgianaemanuela riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT diacmadalinamaria riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT sanduion riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease
AT stefanescugabriela riskpredictorsofadvancedfibrosisinnonalcoholicfattyliverdisease